(Circulation. 1996;94:1528-1536.)
© 1996 American Heart Association, Inc.
Articles |
the Department of Cardiology, the Cleveland Clinic Foundation, Cleveland, Ohio.
Correspondence to Stephen G. Ellis, MD, Director, Sones Cardiac Cath Labs, The Cleveland Clinic Foundation, 9500 Euclid Ave, F-25, Cleveland, OH 44195 or to Alaa E. Abdelmeguid, MD, PhD, Henry Ford Medical Center, Cardiac Catheterization Laboratory (K-2), 2799 W Grand Blvd, Detroit, MI 48202.
Background The clinical significance of minor elevations in creatine kinasemyocardial band isoenzyme (CK-MB) after coronary interventions has not been systematically evaluated.
Methods and Results We examined 4484 patients who underwent successful percutaneous transluminal coronary angioplasty or directional coronary atherectomy and whose peak CK levels did not exceed twice the upper limit of laboratory normal. Group 1 (3776 patients) had no CK or MB elevation after the procedure (ie, CK
180 IU/L, with MB fraction
4%). Group 2 (450 patients) had a peak CK level between 100 and 180 IU/L, with MB fraction >4%, and group 3 (258 patients) had a peak CK level between 181 and 360 IU/L, with MB fraction >4%. The strongest correlate of postprocedure CK-MB elevation was the performance of directional coronary atherectomy (odds ratio, 4.1; P<.0001), followed by the development of
1 in-lab minor procedural complication (odds ratio, 2.6; P<.0001). Clinical follow-up was available in 4461 patients (99.5%), with a mean duration of 36±22 months. Survival analysis, adjusted with Cox proportional hazards regression model, showed that the groups with elevated CK-MB had a significantly higher incidence of cardiac death (risk ratio, 1.3; P=.04) and myocardial infarction (risk ratio, 1.3; P=.03). Major ischemic complications (death, myocardial infarction, and coronary revascularization) occurred more frequently in the groups with increased CK-MB (groups 1 versus 2 versus 3, 37.3% versus 43.3% versus 48.9%; P=.01).
Conclusions This study shows that minor elevations of CK-MB after successful coronary interventions identify a population with a worse long-term prognosis compared with patients with no enzyme elevations and appear to have an adverse effect on long-term prognosis. Future studies of percutaneous coronary revascularization should include routine measurements of biochemical cardiac markers as important predictors of long-term prognosis.
Key Words: creatine kinase angioplasty revascularization enzymes
This article has been cited by other articles:
![]() |
G. Heusch, P. Kleinbongard, D. Bose, B. Levkau, M. Haude, R. Schulz, and R. Erbel Coronary Microembolization: From Bedside to Bench and Back to Bedside Circulation, November 3, 2009; 120(18): 1822 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Lindsey, S. P. Marso, M. Pencina, J. M. Stolker, K. F. Kennedy, C. Rihal, G. Barsness, R. N. Piana, S. L. Goldberg, D. E. Cutlip, et al. Prognostic Impact of Periprocedural Bleeding and Myocardial Infarction After Percutaneous Coronary Intervention in Unselected Patients: Results From the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry J. Am. Coll. Cardiol. Intv., November 1, 2009; 2(11): 1074 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Kumar and D H Roberts Immediate versus deferred coronary angioplasty in non-ST-elevation acute coronary syndromes Heart, September 1, 2009; 95(17): 1455 - 1456. [Full Text] [PDF] |
||||
![]() |
A. Prasad, B. J. Gersh, M. E. Bertrand, A. M. Lincoff, J. W. Moses, E. M. Ohman, H. D. White, S. J. Pocock, B. T. McLaurin, D. A. Cox, et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 477 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Waxman, S. R. Dixon, P. L'Allier, J. W. Moses, J. L. Petersen, D. Cutlip, J.-C. Tardif, R. W. Nesto, J. E. Muller, M. J. Hendricks, et al. In Vivo Validation of a Catheter-Based Near-Infrared Spectroscopy System for Detection of Lipid Core Coronary Plaques: Initial Results of the SPECTACL Study J. Am. Coll. Cardiol. Img., July 1, 2009; 2(7): 858 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uetani, T. Amano, S. Kumagai, H. Ando, K. Yokoi, T. Yoshida, B. Kato, M. Kato, N. Marui, M. Nanki, et al. Intracoronary Electrocardiogram Recording With a Bare-Wire System: Perioperative ST-Segment Elevation in the Intracoronary Electrocardiogram Is Associated With Myocardial Injury After Elective Coronary Stent Implantation J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 127 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Lee, G. S. Mintz, S.-Y. Kim, Y. J. Hong, S. W. Kim, T. Okabe, A. D. Pichard, L. F. Satler, K. M. Kent, W. O. Suddath, et al. Attenuated Plaque Detected by Intravascular Ultrasound: Clinical, Angiographic, and Morphologic Features and Post-Percutaneous Coronary Intervention Complications in Patients With Acute Coronary Syndromes J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, C. S. Rihal, R. J. Lennon, M. Singh, A. S. Jaffe, and D. R. Holmes Jr Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary Intervention: An Analysis of Preintervention and Postintervention Troponin T Levels in 5487 Patients Circ Cardiovasc Interv, August 1, 2008; 1(1): 10 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uetani, T. Amano, H. Ando, K. Yokoi, K. Arai, M. Kato, N. Marui, M. Nanki, T. Matsubara, H. Ishii, et al. The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation Eur. Heart J., July 2, 2008; 29(14): 1714 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Wang, E. D. Peterson, D. Dai, H. V. Anderson, S. V. Rao, R. G. Brindis, M. T. Roe, and on behalf of the National Cardiovascular Data Regi Patterns of Cardiac Marker Surveillance After Elective Percutaneous Coronary Intervention and Implications for the Use of Periprocedural Myocardial Infarction as a Quality Metric: A Report From the National Cardiovascular Data Registry (NCDR) J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2068 - 2074. [Full Text] [PDF] |
||||
![]() |
A. Nusca, R. Melfi, and G. Di Sciascio Review: Percutaneous coronary interventions and statins therapy Therapeutic Advances in Cardiovascular Disease, April 1, 2008; 2(2): 101 - 107. [Abstract] [PDF] |
||||
![]() |
W. D Cahoon Jr and M. A Crouch Preprocedural Statin Therapy in Percutaneous Coronary Intervention Ann. Pharmacother., October 1, 2007; 41(10): 1687 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prasad, M. Singh, A. Lerman, R. J. Lennon, D. R. Holmes Jr, and C. S. Rihal Isolated Elevation in Troponin T After Percutaneous Coronary Intervention Is Associated With Higher Long-Term Mortality J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1765 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Balian, M. Galli, C. Marcassa, G. Cecchin, M. Child, F. Barlocco, E. Petrucci, G. Filippini, R. Michi, and M. Onofri Intracoronary ST-Segment Shift Soon After Elective Percutaneous Coronary Intervention Accurately Predicts Periprocedural Myocardial Injury Circulation, October 31, 2006; 114(18): 1948 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuduvalli, N. Newall, A. Stott, A. D. Grayson, and B. M. Fabri Impact of avoiding cardiopulmonary bypass for coronary surgery on perioperative cardiac enzyme release and survival. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 729 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Okmen, N. Cam, A. Sanli, S. Unal, Z. Tartan, and M. Vural Cardiac Troponin I Increase After Successful Percutaneous Coronary Angioplasty: Predictors and Long-Term Prognostic Value Angiology, March 1, 2006; 57(2): 161 - 169. [Abstract] [PDF] |
||||
![]() |
R. Glaser, H. A. Glick, H. C. Herrmann, and S. E. Kimmel The Role of Risk Stratification in the Decision to Provide Upstream Versus Selective Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes: A Cost-Effectiveness Analysis J. Am. Coll. Cardiol., February 7, 2006; 47(3): 529 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herrmann Peri-procedural myocardial injury: 2005 update Eur. Heart J., December 1, 2005; 26(23): 2493 - 2519. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Arakawa, Y. Kawai, T. Kumamoto, N. Morikawa, M. Yoshida, H. Tada, R. Kawaguchi, K. Taniguchi, I. Miyamori, Y. Kominato, et al. Serum deoxyribonuclease I activity can be used as a sensitive marker for detection of transient myocardial ischaemia induced by percutaneous coronary intervention Eur. Heart J., November 2, 2005; 26(22): 2375 - 2380. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Tadros, K. Broder, and F. Bachour Intracoronary Macrothrombus Formation During Percutaneous Coronary Intervention Despite Optimal Activated Clotting Time Using Bivalirudin: A Case Report Angiology, November 1, 2005; 56(6): 761 - 765. [Abstract] [PDF] |
||||
![]() |
D. Paparella, G. Cappabianca, G. Visicchio, A. Galeone, A. Marzovillo, N. Gallo, C. Memmola, and L. d. L. T. Schinosa Cardiac Troponin I Release After Coronary Artery Bypass Grafting Operation: Effects on Operative and Midterm Survival Ann. Thorac. Surg., November 1, 2005; 80(5): 1758 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Boden Acute Coronary Syndromes without ST-Segment Elevation -- What Is the Role of Early Intervention? N. Engl. J. Med., September 15, 2005; 353(11): 1159 - 1161. [Full Text] [PDF] |
||||
![]() |
T Nageh, R A Sherwood, B M Harris, and M R Thomas Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease Heart, September 1, 2005; 91(9): 1181 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Bahrmann, H R Figulla, M Wagner, M Ferrari, A Voss, and G S Werner Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions Heart, September 1, 2005; 91(9): 1186 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mizote, Y. Ueda, T. Ohtani, M. Shimizu, Y. Takeda, T. Oka, M. Tsujimoto, A. Hirayama, M. Hori, and K. Kodama Distal Protection Improved Reperfusion and Reduced Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Who Had Angioscopically Defined Ruptured Plaque Circulation, August 16, 2005; 112(7): 1001 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Bhatt and E. J. Topol Periprocedural Cardiac Enzyme Elevation Predicts Adverse Outcomes Circulation, August 9, 2005; 112(6): 906 - 922. [Full Text] [PDF] |
||||
![]() |
D. E. Cutlip and R. E. Kuntz Cardiac Enzyme Elevation After Successful Percutaneous Coronary Intervention Is Not an Independent Predictor of Adverse Outcomes Circulation, August 9, 2005; 112(6): 916 - 923. [Full Text] [PDF] |
||||
![]() |
C. Cavallini, S. Savonitto, R. Violini, G. Arraiz, M. Plebani, Z. Olivari, P. Rubartelli, S. Battaglia, L. Niccoli, G. Steffenino, et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study Eur. Heart J., August 1, 2005; 26(15): 1494 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Briguori, A. Colombo, F. Airoldi, A. Violante, A. Focaccio, P. Balestrieri, P. Paolo Elia, B. Golia, S. Lepore, G. Riviezzo, et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction Eur. Heart J., October 2, 2004; 25(20): 1822 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jeremias, D. S. Baim, K. K.L. Ho, M. Chauhan, J. P. Carrozza Jr, D. J. Cohen, J. J. Popma, R. E. Kuntz, and D. E. Cutlip Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1210 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Okmen, N. Cam, A. Sanli, F. Yapici, H. Uyarel, M. Vural, and R. Ozturk Effects of Direct Stent Implantation and Conventional Stent Implantation on Minor Myocardial Injury Angiology, September 1, 2004; 55(5): 485 - 491. [Abstract] [PDF] |
||||
![]() |
V. Pasceri, G. Patti, A. Nusca, C. Pristipino, G. Richichi, G. Di Sciascio, and on behalf of the ARMYDA Investigators Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study Circulation, August 10, 2004; 110(6): 674 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Angelini, P. Rubartelli, F. Mistrorigo, M. Della Barbera, F. Abbadessa, M. Vischi, G. Thiene, and S. Chierchia Distal Protection With a Filter Device During Coronary Stenting in Patients With Stable and Unstable Angina Circulation, August 3, 2004; 110(5): 515 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.T. Roe, K.W. Mahaffey, R. Kilaru, J.H. Alexander, K.M. Akkerhuis, M.L. Simoons, R.A. Harrington, B.E. Tardiff, C.B. Granger, E.M. Ohman, et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes Eur. Heart J., February 2, 2004; 25(4): 313 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Miller, K. N. Garratt, M. F. Burritt, G. S. Reeder, and A. S. Jaffe Timing of Peak Troponin T and Creatine Kinase-MB Elevations After Percutaneous Coronary Intervention Chest, January 1, 2004; 125(1): 275 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K French and H. D White Clinical implications of the new definition of myocardial infarction Heart, January 1, 2004; 90(1): 99 - 106. [Full Text] [PDF] |
||||
![]() |
I. Iakovou, G. S. Mintz, G. Dangas, A. Abizaid, R. Mehran, Y. Kobayashi, A. J. Lansky, E. D. Aymong, E. Nikolsky, G. W. Stone, et al. Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1900 - 1905. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Calafiore, M. Di Mauro, C. Canosa, G. Di Giammarco, A. L. Iaco, and M. Contini Myocardial revascularization with and without cardiopulmonary bypass: advantages, disadvantages and similarities Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 953 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. A. Ioannidis, E. Karvouni, and D. G. Katritsis Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1406 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Nallamothu and E. R. Bates Periprocedural myocardial infarction and mortality: Causality versus association J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1412 - 1414. [Full Text] [PDF] |
||||
![]() |
R. A. Henderson, S. J. Pocock, T. C. Clayton, R. Knight, K. A. A. Fox, D. G. Julian, D. A. Chamberlain, and Second Randomized Intervention Treatment of Angina Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1161 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Levine, M. J. Kern, P. B. Berger, D. L. Brown, L. W. Klein, D. J. Kereiakes, T. A. Sanborn, A. K. Jacobs, and for the American Heart Association Diagnostic and Management of Patients Undergoing Percutaneous Coronary Revascularization Ann Intern Med, July 15, 2003; 139(2): 123 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Kizer, M. R. Muttrej, W. H. Matthai, J. McConnell, H. Nardone, A. F. Sonel, M. G. Keane, and R. L. Wilensky Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention Eur. Heart J., July 2, 2003; 24(14): 1314 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. Wang, A. Osman, J. Otero, G. A. Stouffer, S. Waxman, A. Afzal, A. Anzuini, and B. F. Uretsky Distal Myocardial Protection During Percutaneous Coronary Intervention With an Intracoronary {beta}-Blocker Circulation, June 17, 2003; 107(23): 2914 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, H. Ito, K. Iwakura, S. Kawano, M. Ikushima, T. Masuyama, T. Ogihara, and K. Fujii Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: Insight into mechanisms of microvascular dysfunction J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1755 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Ellis, D. Chew, A. Chan, P. L. Whitlow, J. P. Schneider, and E. J. Topol Death Following Creatine Kinase-MB Elevation After Coronary Intervention: Identification of an Early Risk Period: Importance of Creatine Kinase-MB Level, Completeness of Revascularization, Ventricular Function, and Probable Benefit of Statin Therapy Circulation, September 3, 2002; 106(10): 1205 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
W J R Desmet, J Dens, P Coussement, and F Van de Werf Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial Heart, September 1, 2002; 88(3): 293 - 295. [Full Text] [PDF] |
||||
![]() |
A. W. Bonz, B. Lengenfelder, J.o. Strotmann, S. Held, O. Turschner, K. Harre, C. Wacker, C. Waller, N. Kochsiek, M. Meesmann, et al. effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial) J. Am. Coll. Cardiol., August 21, 2002; 40(4): 662 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Cantor, L. K. Newby, R. H. Christenson, R. H. Tuttle, V. Hasselblad, P. W. Armstrong, D. J. Moliterno, R. M. Califf, E. J. Topol, E. M. Ohman, et al. Prognostic significance of elevated troponin i after percutaneous coronary intervention J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1738 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Colombo and G. Stankovic Nothing is lower than 0, and 3 is closer to 0 than to 5--medicine is not arithmetic Eur. Heart J., June 1, 2002; 23(11): 840 - 842. [Full Text] [PDF] |
||||
![]() |
B. J. Riedel and A. D. Shaw Thoracic Epidural Anesthesia & Analgesia in Patients Undergoing Coronary Artery Bypass Surgery Anesth. Analg., May 1, 2002; 94(5): 1365 - 1365. [Full Text] [PDF] |
||||
![]() |
T. Nageh, R. A. Sherwood, and M. R. Thomas Prognostic Implications of Cardiac Marker Elevation After Percutaneous Coronary Intervention Circulation, March 26, 2002; 105 (12): e73 - e73. [Full Text] [PDF] |
||||
![]() |
K. M. Akkerhuis, J. H. Alexander, B. E. Tardiff, E. Boersma, R. A. Harrington, A. M. Lincoff, and M. L. Simoons Minor Myocardial Damage and Prognosis: Are Spontaneous and Percutaneous Coronary Intervention-Related Events Different? Circulation, February 5, 2002; 105(5): 554 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Costa, R. G. Carere, S. V. Lichtenstein, D. P. Foley, V. de Valk, W. Lindenboom, P. C.H. Roose, T. R. van Geldorp, C. Macaya, J. L. Castanon, et al. Incidence, Predictors, and Significance of Abnormal Cardiac Enzyme Rise in Patients Treated With Bypass Surgery in the Arterial Revascularization Therapies Study (ARTS) Circulation, November 27, 2001; 104(22): 2689 - 2693. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. GONZI, P. A. MERLINI, and D. ARDISSINO Invasive coronary revascularisation is better than conservative treatment in patients with acute coronary syndromes Heart, October 1, 2001; 86(4): 363 - 364. [Full Text] [PDF] |
||||
![]() |
J. C. Blankenship, G. Tasissa, J. C. O'Shea, E. A. Iliadis, F. A. Bachour, D. J. Cohen, H. K. Lui, T. Mann III, E. Cohen, J. E. Tcheng, et al. Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial J. Am. Coll. Cardiol., September 1, 2001; 38(3): 653 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Stone, R. Mehran, G. Dangas, A. J. Lansky, R. Kornowski, and M. B. Leon Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention: A Device-Specific Analysis of 7147 Patients Circulation, August 7, 2001; 104(6): 642 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ricciardi, E. Wu, C. J. Davidson, K. M. Choi, F. J. Klocke, R. O. Bonow, R. M. Judd, and R. J. Kim Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation Circulation, June 12, 2001; 103(23): 2780 - 2783. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Herrmann, M. Haude, A. Lerman, R. Schulz, L. Volbracht, J. Ge, A. Schmermund, H. Wieneke, C. von Birgelen, H. Eggebrecht, et al. Abnormal Coronary Flow Velocity Reserve After Coronary Intervention Is Associated With Cardiac Marker Elevation Circulation, May 15, 2001; 103(19): 2339 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Vetrovec Acute and Delayed Benefits of {beta}-Blockers During Coronary Intervention : True, True and Unrelated Circulation, July 11, 2000; 102(2): 147 - 148. [Full Text] [PDF] |
||||
![]() |
R. Erbel and G. Heusch Coronary microembolization J. Am. Coll. Cardiol., July 1, 2000; 36(1): 22 - 24. [Full Text] [PDF] |
||||
![]() |
A.M. Lincoff and E.J. Topol Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven? Eur. Heart J., June 1, 2000; 21(11): 863 - 867. [PDF] |
||||
![]() |
J. M. Ahmed, M. K. Hong, R. Mehran, G. S. Mintz, A. J. Lansky, A. D. Pichard, L. F. Satler, K. M. Kent, H. Wu, G. W. Stone, et al. Comparison of debulking followed by stenting versus stenting alone for saphenous vein graft aortoostial lesions: immediate and one-year clinical outcomes J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1560 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Saucedo, R. Mehran, G. Dangas, M. K. Hong, A. Lansky, K. M. Kent, L. F. Satler, A. D. Pichard, G. W. Stone, and M. B. Leon Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1134 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Harrington Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation and mortality J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1142 - 1144. [Full Text] [PDF] |
||||
![]() |
N. S. Kleiman, A. M. Lincoff, G. C. Flaker, K. S. Pieper, R. G. Wilcox, L. G. Berdan, T. J. Lorenz, D. V. Cokkinos, M. L. Simoons, E. Boersma, et al. Early Percutaneous Coronary Intervention, Platelet Inhibition With Eptifibatide, and Clinical Outcomes in Patients With Acute Coronary Syndromes Circulation, February 22, 2000; 101(7): 751 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mehran, G. Dangas, G. S. Mintz, A. J. Lansky, A. D. Pichard, L. F. Satler, K. M. Kent, G. W. Stone, and M. B. Leon Atherosclerotic Plaque Burden and CK-MB Enzyme Elevation After Coronary Interventions : Intravascular Ultrasound Study of 2256 Patients Circulation, February 15, 2000; 101(6): 604 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Topol and J. S. Yadav Recognition of the Importance of Embolization in Atherosclerotic Vascular Disease Circulation, February 8, 2000; 101(5): 570 - 580. [Full Text] [PDF] |
||||
![]() |
J. H. Alexander, R. A. Sparapani, K. W. Mahaffey, J. W. Deckers, L. K. Newby, E. M. Ohman, R. Corbalan, S. L. Chierchia, J. B. Boland, M. L. Simoons, et al. Association Between Minor Elevations of Creatine Kinase-MB Level and Mortality in Patients With Acute Coronary Syndromes Without ST-Segment Elevation JAMA, January 19, 2000; 283(3): 347 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Hong, R. Mehran, G. Dangas, G. S. Mintz, A. J. Lansky, A. D. Pichard, K. M. Kent, L. F. Satler, G. W. Stone, and M. B. Leon Creatine Kinase-MB Enzyme Elevation Following Successful Saphenous Vein Graft Intervention Is Associated With Late Mortality Circulation, December 14, 1999; 100(24): 2400 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kini, J. D. Marmur, S. Kini, G. Dangas, T. P. Cocke, S. Wallenstein, E. Brown, J. A. Ambrose, and S. K. Sharma Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary intervention J. Am. Coll. Cardiol., September 1, 1999; 34(3): 663 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Laskey Beneficial Impact of Preconditioning During PTCA on Creatine Kinase Release Circulation, April 27, 1999; 99(16): 2085 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Lincoff, J. E. Tcheng, R. M. Califf, D. J. Kereiakes, T. A. Kelly, G. C. Timmis, N. S. Kleiman, J. E. Booth, C. Balog, C. F. Cabot, et al. Sustained Suppression of Ischemic Complications of Coronary Intervention by Platelet GP IIb/IIIa Blockade With Abciximab : One-Year Outcome in the EPILOG Trial Circulation, April 20, 1999; 99(15): 1951 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zimmerman, R. Fromm, D. Meyer, A. Boudreaux, C.-C. C. Wun, R. Smalling, B. Davis, G. Habib, and R. Roberts Diagnostic Marker Cooperative Study for the Diagnosis of Myocardial Infarction Circulation, April 6, 1999; 99(13): 1671 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Koch, J. vom Dahl, E. Kleinhans, H. G. Klues, P. W. Radke, S. Ninnemann, G. Schulz, U. Buell, and P. Hanrath Influence of a platelet GPIIb/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m sestamibi scintigraphy J. Am. Coll. Cardiol., March 15, 1999; 33(4): 998 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Narins, D. P. Miller, R. M. Califf, and E. J. Topol The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization: Insights from the EPIC trial J. Am. Coll. Cardiol., March 1, 1999; 33(3): 647 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Piana, W. H. Ahmed, B. Chaitman, P. Ganz, S. Kinlay, J. Strony, B. Adelman, J. A. Bittl, and on behalf of the Hirulog Angioplasty Study Investi Effect of transient abrupt vessel closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months J. Am. Coll. Cardiol., January 1, 1999; 33(1): 73 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Tardiff, R. M. Califf, J. E. Tcheng, A. M. Lincoff, K. N. Sigmon, R. A. Harrington, K. W. Mahaffey, E. M. Ohman, P. S. Teirstein, J. C. Blankenship, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention J. Am. Coll. Cardiol., January 1, 1999; 33(1): 88 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Steinhubl, M. S. Lauer, D. P. Mukherjee, D. J. Moliterno, A. M. Lincoff, S. G. Ellis, and E. J. Topol The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1366 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Topol and P. W. Serruys Frontiers in Interventional Cardiology Circulation, October 27, 1998; 98(17): 1802 - 1820. [Full Text] [PDF] |
||||
![]() |
I. Moussa, J. Moses, C. Di Mario, G. Busi, B. Reimers, Y. Kobayashi, R. Albiero, M. Ferraro, and A. Colombo Stenting After Optimal Lesion Debulking (SOLD) Registry : Angiographic and Clinical Outcome Circulation, October 20, 1998; 98(16): 1604 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
International, Randomized, Controlled Trial of Lamifiban (a Platelet Glycoprotein IIb/IIIa Inhibitor), Heparin, or Both in Unstable Angina Circulation, June 23, 1998; 97(24): 2386 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Coudrey The Troponins Arch Intern Med, June 8, 1998; 158(11): 1173 - 1180. [Full Text] [PDF] |
||||
![]() |
R. Kornowski, R. Mehran, M. K. Hong, L. F. Satler, A. D. Pichard, K. M. Kent, G. S. Mintz, R. Waksman, J. R. Laird, A. J. Lansky, et al. Procedural Results and Late Clinical Outcomes After Placement of Three or More Stents in Single Coronary Lesions Circulation, April 14, 1998; 97(14): 1355 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Baim, D. E. Cutlip, S. K. Sharma, K. K. L. Ho, R. Fortuna, T. L. Schreiber, R. L. Feldman, J. Shani, C. Senerchia, Y. Zhang, et al. Final Results of the Balloon vs Optimal Atherectomy Trial (BOAT) Circulation, February 3, 1998; 97(4): 322 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Khan, J. Forrester, G. Gambassi, R. Landolfi, R. Bernabei, A. M. Lincoff, E. J. Topol, R. M. Califf, and D. R. Holmes Platelet Glycoprotein IIb/IIIa Receptor Blockade after Coronary Angioplasty N. Engl. J. Med., October 23, 1997; 337(17): 1243 - 1245. [Full Text] |
||||
![]() |
E. J. Topol, J. J. Ferguson, H. F. Weisman, J. E. Tcheng, S. G. Ellis, N. S. Kleiman, R. J. Ivanhoe, A. L. Wang, D. P. Miller, K. M. Anderson, et al. Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin {beta}3 Blockade With Percutaneous Coronary Intervention JAMA, August 13, 1997; 278(6): 479 - 484. [Abstract] [PDF] |
||||
![]() |
D. L. Fischman and M. P. Savage The Platelet, the Patient, and Periprocedural Infarction During Percutaneous Transluminal Coronary Angioplasty JAMA, August 13, 1997; 278(6): 518 - 519. [Abstract] [PDF] |
||||
![]() |
The EPILOG Investigators Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization N. Engl. J. Med., June 12, 1997; 336(24): 1689 - 1697. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Ohman and B. E. Tardiff Periprocedural Cardiac Marker Elevation After Percutaneous Coronary Artery Revascularization: Importance and Implications JAMA, February 12, 1997; 277(6): 495 - 497. [Abstract] [PDF] |
||||
![]() |
A. E. Abdelmeguid and E. J. Topol The Myth of the Myocardial `Infarctlet' During Percutaneous Coronary Revascularization Procedures Circulation, December 15, 1996; 94(12): 3369 - 3375. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |